Chengdu-Chongqing Metropolitan Area forms an urban agglomeration with Chengdu and Chongqing as the core, which is an important platform for the development of the western region. Development conditions: Chengdu-Chongqing area is densely populated, rich in production factors, and has a broad prospect in the biomedical market. The western region is strongly supported by Z policy, connecting the northwest and southwest regions.
Representative industrial parks Chengdu High-tech Zone Biomedical Industrial Park Chengdu Tianfu International Biological City, Chongqing Liangjiang New District, Chongqing High-tech Zone and Banan Chongqing International Biological City. Some pharmaceutical companies in the metropolitan area, Ou Lin Bio, Zhien Bio, Kang Hua Bio, Leading Pharmaceutical, zhifei Bio and Haichuang Pharmaceutical. The Yangtze River Delta region with Shanghai and Suzhou as the core. Nanjing, Hangzhou, Taizhou Lianyungang, Wuxi and other characteristic clusters are distributed in many places.
Development conditions: efficient coordination among cities, industrial agglomeration, innovative resource development and multi-level scientific research have obvious advantages, and the level of international exchanges is high. Related industrial parks: Shanghai Zhangjiang Medicine Valley, Suzhou Biomedical Industrial Park, Nanjing Biomedical Valley, Lianyungang Economic Development Zone and Hangzhou Medicine Port.
Some pharmaceutical companies in the Yangtze River Delta, Fosun Pharma, Hengrui Pharma, Green Valley Pharmaceutical Haosen Pharmaceutical, Beida Pharmaceutical, Junshi Bio-medicine, Zheng Da Tianqing, etc. ...
Guangdong-Hong Kong-Macao Greater Bay Area. Development conditions: Take Guangzhou and Shenzhen as the core cities for development, and extend to Dongguan, Foshan, Zhongshan, Zhuhai and other cities for coordinated development. With the advantages of information technology industry, a relatively complete biomedical industry chain has been formed, with the strong support of Z-policy, and the resources of Hong Kong and Macao have been integrated. Representative industrial parks, Guangzhou International Biological Island, Guangzhou Scientific Representative Industrial Park City, Zhuhai Jinwan Biomedical Base, Zhongshan National Health Science and Technology Industrial Base, etc. ...
Some pharmaceutical enterprises in Guangdong, Hong Kong and Macao, Shanghai, Livzon Medicine, Baiyun Shandong Sunshine, Guangzhou Pharmaceutical Group, Kangfang Bio, China Resources Sanjiu, Xinlitai and other enterprises. In the Bohai Rim region, Beijing, Tianjin, Shijiazhuang, Jinan, Yantai and other cities have formed a huge pharmaceutical industry chain.
Development conditions: talents, funds and other scientific research resources with unique location, Z strategy, rich advantages in evaluation and approval, and strong basic research ability.
Related industrial parks: Beijing Yizhuang Biomedical Park, Zhongguancun Life Science Park, Daxing Biomedical Industrial Base, Shijiazhuang High-tech Zone, Jinan High-tech Zone Life Science City. Some pharmaceutical companies around Bohai Sea, Baekje Shenzhou, Qilu Pharmaceutical, Yiling Pharmaceutical, Chen Xin Pharmaceutical, Tasly, etc.
Overview of biomedicine and industrial parks: Biomedical industrial parks are mainly distributed in four areas: Bohai Rim, Yangtze River, Pearl River Delta and Chengdu-Chongqing metropolitan area. Each region has its own development advantages, attracting leading enterprises to settle in and forming industrial clusters. By 2002 1, about 80% of listed companies, 90% of national1new drugs and 85% of innovative medical device special approval products come from the above four regions.